Postmenopausal hormone therapy and its association with breast cancer
With the cessation of estrogen and progesterone at menopause, the hormone withdrawal affects various systems in the woman's body. In earlier days, menopausal hormone therapy (HT) was prescribed for primary prevention of coronary artery disease (CAD) and osteoporosis, which were thought to be be...
Main Authors: | Arshi Syal, Neelam Aggarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Mid-Life Health |
Subjects: | |
Online Access: | http://www.jmidlifehealth.org/article.asp?issn=0976-7800;year=2020;volume=11;issue=4;spage=187;epage=195;aulast=Syal |
Similar Items
-
Hormone therapy for postmenopausal women
by: J. V. Pinkerton
Published: (2020-12-01) -
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
by: Irene Lambrinoudaki
Published: (2021-01-01) -
Menopausal hormone therapy and risk factors of breast cancer development
by: A E Protasova, et al.
Published: (2017-06-01) -
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
by: Yu Deng, et al.
Published: (2022-04-01) -
Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
by: Beomyoung Cho, et al.
Published: (2022-08-01)